Literature DB >> 2142441

Graft-versus-host disease associated T helper cell responses specific for minor histocompatibility antigens are mainly restricted by HLA-DR molecules.

C A van Els1, E Zantvoort, N Jacobs, A Bakker, J J van Rood, E Goulmy.   

Abstract

Graft-versus-host reactions are mediated by subpopulations of donor T cells and can be attributed to host specific minor histocompatibility (mH) antigens. We isolated strong anti-host mH antigen proliferative T cell lines, LG2, PN2, and LH3, from three patients suffering from acute graft-versus-host disease (GVHD). To study the role of the different major histocompatibility complex (MHC) molecules in the anti-host mH antigen specific proliferative response, the reactivities of the three T cell lines were analysed in primed lymphocyte test (PLT) assays against panels of stimulator cells obtained from unrelated blood donors. LG2 and LH3 stimulating determinants were commonly detected in the unrelated panel, whereas the PN2 T cell line recognized a rare specificity. The responses were associated with the presence of self HLA-DR molecules on the stimulator cells, although not all DR sharing stimulator cells were recognized. The proliferative responses of LG2, LH3 and PN2 cells could be blocked by monoclonal antibodies (MoAbs) against HLA-DR, but not by MoAbs against HLA-A/B/Cw, HLA-DQ or -DP. At the responder cell level, depletion of CD4 cells as well as blocking with CD4 specific MoAbs abrogated the specific responses of the three T cell lines. Our findings suggest that anti-host Th cell responses activated in the acute phase of GVHD are directed against both frequent and rare mH antigens, are mediated by CD4 + ve class II restricted Th cells, and use the HLA-DR molecule as a common restriction element for mH antigen presentation.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 2142441

Source DB:  PubMed          Journal:  Bone Marrow Transplant        ISSN: 0268-3369            Impact factor:   5.483


  5 in total

1.  Transfected human class I gene product adequately assembles minor histocompatibility antigens.

Authors:  E Goulmy; J Pool; E Blokland; D Geraghty
Journal:  Immunogenetics       Date:  1991       Impact factor: 2.846

Review 2.  Current thoughts on the pathogenesis of graft versus host disease.

Authors:  A L Appleton; L Sviland
Journal:  J Clin Pathol       Date:  1993-09       Impact factor: 3.411

3.  A genetic analysis of human minor histocompatibility antigens demonstrates Mendelian segregation independent of HLA.

Authors:  G M Schreuder; J Pool; E Blokland; C van Els; A Bakker; J J van Rood; E Goulmy
Journal:  Immunogenetics       Date:  1993       Impact factor: 2.846

4.  Immunogenetics of human minor histocompatibility antigens: their polymorphism and immunodominance.

Authors:  C A van Els; J D'Amaro; J Pool; E Blokland; A Bakker; P J van Elsen; J J van Rood; E Goulmy
Journal:  Immunogenetics       Date:  1992       Impact factor: 2.846

5.  Genome-wide single-nucleotide polymorphism analysis revealed SUFU suppression of acute graft-versus-host disease through downregulation of HLA-DR expression in recipient dendritic cells.

Authors:  Rafijul Bari; Christine Hartford; Wing Keung Chan; Queenie Vong; Ying Li; Kwan Gan; Yinmei Zhou; Cheng Cheng; Guolian Kang; Sheila Shurtleff; Victoria Turner; Ching-Hon Pui; James R Downing; Wing Leung
Journal:  Sci Rep       Date:  2015-06-11       Impact factor: 4.379

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.